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ABSTRACT 
Increased expression of the chondroitin proteoglycan NG2 is a prominent feature in 
CNS injury with unknown cellular source and biological relevance. Here, we describe 
the first detailed analysis of experimental autoimmune encephalomyelitis in NG2ko 
mice and NG2ko bone marrow chimeras. We show that both macrophages and 
oligodendrocyte progenitors cells express and shed NG2 in response to TGF. A 
subpopulation of macrophages expresses NG2 within leukocyte infiltrates in the CNS, 
but only oligodendrocyte progenitor cells contribute to NG2 accumulation. Notably, 
NG2 plays no role in experimental autoimmune encephalomyelitis initiation, 
progression or recuperation. In concurrence, the immune response is unaltered in NG2 
deficient mice as are the extent of CNS damage and degree of remyelination. 
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Introduction 
The glial scar is considered a major obstacle in effective recovery of the CNS from 
insult. Virtual all CNS injuries, including the autoimmune disease Multiple Sclerosis 
(MS), trigger rapid activation of astrocytes, microglia, macrophages and 
oligodendrocyte progenitor cells (OPCs) (Alonso, 2005, Fawcett and Asher, 1999), 
which in turn deposit chondroitin sulfate proteoglycans (CSPGs) (Dou and Levine, 
1994, Laabs et al. , 2007, Tang et al. , 2003). The high molecular weight chondroitin 
proteoglycan NG2 (CSPG-4) is a prominent component of the glial scar (Tan et al. , 
2005, Tang et al. , 2003) and is considered a major obstacle for axon regeneration, 
remyelination and CNS recovery (Chen et al. , 2002, de Castro et al. , 2005, Dou and 
Levine, 1994, Fawcett and Asher, 1999, Laabs et al. , 2007, Larsen et al. , 2003, 
Morgenstern et al. , 2002, Tan et al. , 2005, Tan et al. , 2006, Tang et al. , 2003), 
although this view is now being questioned (de Castro et al. , 2005, Hossain-Ibrahim 
et al. , 2007 Sep 27, Tan et al. , 2006, Ughrin et al. , 2003).  
Although the rapid accumulation of NG2 is a common feature of damage to the CNS, 
the biological role of NG2 in CNS injury is still a conundrum. The short intracellular 
domain of NG2 binds various signaling molecules that may link NG2 to synapses and 
the cytoskeleton. The large extracellular domain (290 kDa) contains several disulfide 
bonds, N-glycosylation sites and a single chondroitin chain and binds a wide array of 
proteins, including receptors, growth factors, extracellular matrix components, and 
proteases indicating that NG2 may regulate diverse cellular processes (Nishiyama et 
al. , 2009, Stallcup, 2002, Trotter et al. , 2010 May). Importantly, the extracellular 
domain of NG2 can be cleaved off and incorporated into the extracellular matrix 
(Asher et al. , 2005, Nishiyama et al. , 1995). The high concentration of proteases and 
large numbers of NG2 expressing cells at sites of inflammation in the CNS may 
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explain the high amount of NG2 in the glial scar. The biological function of NG2 
shedding in response to CNS injury remains to be addressed. 
Surprisingly, the cellular source of NG2 in areas of CNS damage has become a matter 
of debate. Although OPCs are generally considered responsible for NG2 
accumulation (NG2 is a marker for these cells (Nishiyama et al. , 2009, Trotter et al. , 
2010 May)) recent reports indicate that activated microglia and CNS-infiltrating 
macrophages may also express NG2 after CNS injury (Bu et al. , 2001, Fiedorowicz 
et al. , 2008, Jones et al. , 2002, Matsumoto et al. , 2008, Smirkin et al. , 2009 Mar, 
Yokoyama et al. , 2006, Zhu et al. ). Blood-derived monocytes/macrophages and 
microglia play pivotal roles in CNS injury and can cause extensive CNS damage 
including axonopathy and demyelination, events that trigger substantial OPC 
activation and glial scar formation (Alonso, 2005, Di Bello et al. , 1999, Foote and 
Blakemore, 2005, Mildner et al. , 2009, Reynolds et al. , 2002, Rhodes et al. , 2006). 
Importantly, NG2 may mediate the inflammatory response of activated microglia 
(Gao et al. , 2010). However the signals triggering NG2 expression in macrophages 
and microglia are currently unknown and whether these cells do contribute to NG2 
accumulation - and their large numbers at sites of inflammation and in the glial scar 
support such a notion – has not been addressed yet.  
In this study we have investigated the cellular source(s) of deposited NG2, the signals 
triggering NG2 expression and its function in MOG-induced experimental 
autoimmune encephalomyelitis (EAE), the murine model system for MS. We show 
that TGF up regulates NG2 expression and secretion by OPCs and macrophages and 
demonstrate that NG2 is redundant in EAE progression, recruitment of leukocytes 
into the CNS, neuronal damage, demyelination and, importantly, remyelination. 
Finally, we prove that blood-derived macrophages express NG2 in the CNS during 
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EAE but do not contribute to the accumulation of NG2 at sites of inflammation. Our 
data excludes a prominent role for NG2 in immune regulation and regeneration in 
autoimmune inflammation of the CNS. 
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Results 
NG2 protein accumulates at sites of infiltrating leukocytes in EAE. 
In the injured CNS, NG2 protein levels are often elevated at sites of tissue damage 
and/or inflammation and increased NG2 levels remain associated with the glial scar 
(Alonso, 2005, Fawcett and Asher, 1999, Levine, 1994, Morgenstern et al. , 2002, 
Tan et al. , 2005, Tan et al. , 2006). However, in EAE and MS, changes in NG2 levels 
have been less well described (Di Bello et al. , 1999, Reynolds et al. , 2002). 
Examination of NG2 and cytokine mRNA expression by quantitative RT-PCR in the 
spinal cord at different EAE disease stages showed that at peak disease on day 18 
post-immunization (p.i.) (average score 2.78±0.15) NG2 mRNA levels are 
significantly elevated and remain elevated in the remission phase (rem.; day 43 p.i., 
average score 2.13±0.07) (Fig. 1A). Notably, the NG2 expression profile correlates 
well with the expression of TGF in the spinal cord, with high expression maintained 
in the remission phase (Fig. 1A). In contrast mRNA expression levels of IL-2, IL-6, 
IL-10, TNF, and IFN subsided after the peak phase (Fig. 1A).  
Since NG2 exists in both cell-bound and secreted forms (Asher et al. , 2005, 
Nishiyama et al. , 1995, Stallcup, 2002), we examined the expression of both soluble 
and detergent-extracted NG2 protein in spinal cord at different EAE stages by 
Western blot (Fig. 1B). Both the 300-kDa cell-bound and 290-kDa shed forms of 
NG2 are significantly elevated during EAE. The highest amount of detergent-
extracted NG2 is detected at the peak phase whereas soluble NG2 increased over the 
course of the disease (Fig. 1B and C). 
We investigated by immunohistochemistry if the increase in NG2 protein was 
restricted to sites of leukocyte infiltration in the spinal cord (Fig. 1D). In the spinal 
cord of healthy mice (naïve), NG2 is expressed by pericytes associated with blood 
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vessels, meningeal cells and OPCs (insert shows the typical stellar appearance of 
OPCs). NG2 expression typical for the meninges (arrow) and satellite cells of the 
dorsal root ganglia (arrow head) are illustrated in the remission panel (rem.). At peak 
disease (peak), NG2-immunoreactivity is clearly elevated within and around the 
borders of the area occupied by infiltrating leukocytes (outlined area). Importantly, 
within and in close proximity of these sites of leukocyte infiltration, Olig2+ OPCs are 
abundantly present (Supplementary Fig. 3). Note that within infiltrates some areas are 
completely devoid of NG2-immunoreactivity, probably a sign of extensive tissue 
damage. The insert illustrates that NG2 is no longer restricted to stellar OPCs but now 
has a rather diffuse distribution, which is maintained at the remission stage of EAE 
(rem.). In contrast, in the normal appearing spinal cord at remission (rem. n.a. Sp.C.), 
distribution of NG2 is indistinguishable from its distribution in healthy mice. Thus 
both cell-bound and secreted NG2 are up regulated in the spinal cord during EAE and 
accumulate at sites of leukocyte infiltration. 
 
TGF increases NG2 expression and secretion by macrophages and OPCs. 
During EAE the CNS is subjected to a steep increase in the concentration of disease-
mediating cytokines (Fig. 1A) that could potentially trigger NG2 accumulation by 
increasing OPC numbers and/or NG2 expression by OPCs. In addition to OPCs, both 
macrophages and the CNS-resident microglia are potential producers of NG2 (Bu et 
al. , 2001, Fiedorowicz et al. , 2008, Jones et al. , 2002, Matsumoto et al. , 2008, 
Smirkin et al. , 2009 Mar, Yokoyama et al. , 2006, Zhu et al. , 2010 Mar 31).  
We treated bone marrow-derived macrophages and the OPC cell line OLIneu with a 
variety of cytokines with known roles in EAE, followed by quantitative RT-PCR 
analysis. Notably, only TGF increases expression of NG2 mRNA in both OLIneu 
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and macrophages (Fig. 2A). In addition IL-6 increased NG2 expression in OLIneu to 
a similar extent. Subsequent 3H-thymidine incorporation assays indicated that the 
TGF-induced increase in NG2 mRNA in OLIneu is not due to enhanced 
proliferation (Supplementary Fig. 1). To test if primary OPCs are capable of secreting 
NG2 and if secreted and/or cell-bound NG2 protein levels are altered by TGF, OPC-
conditioned media and cell lysates were analyzed by Western blotting (Fig. 2B). 
TGF-treatment of primary OPCs demonstrated that both secreted and cell-bound 
NG2 amounts increase after 48 hrs. A time course of TGF-treatment of OLIneu 
confirmed these results (Supplementary Fig. 2). Collectively these data show that 
TGF treatment of OPCs induces an increase in cell-bound and secreted NG2 without 
influencing cell proliferation. 
To investigate if macrophages and/or microglia express NG2 protein and possibly 
secrete NG2 in response to cytokines we treated bone-marrow derived macrophages 
and the microglial cell line BV2 (Bocchini et al. , 1992) with IL-10, TNF, IFN or 
TGF and analyzed their conditioned media and cell lysates by Western blotting. 
Although untreated macrophages express a small amount of NG2, TGF triggers a 
significant increase in both cell-bound and secreted NG2 (Fig. 2C and D). In contrast, 
untreated microglia do not express NG2 and TGF induced expression of a small 
amount of cell-bound, but not secreted, NG2 (Fig. 2E). Notably, a comparative 
Western blot showed that the amount of cell-bound NG2 expressed by microglia is 
negligible and barely visible compared to the amount produced by either macrophages 
or OPCs, with the latter producing the highest amount of cell-bound NG2 (Fig. 2F). 
Subsequent immunocytochemical analysis (Fig. 2G) showed that OLIneu cells are 
always NG2+ and TGF treatment elicits a modest increase in NG2 immunoreactivity. 
Untreated macrophages are primarily NG2- although occasionally a NG2+ cell is 
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detected. TGF treatment triggers a substantial increase in the number of NG2+ 
macrophages but the intensity of NG2-immunoreactivity varies between cells. 
Notably, NG2 immunoreactivity was never observed in microglia after any of the 
treatments. In summary, these data indicate that both macrophages and OPCs up 
regulate NG2 expression and secretion in response to TGF whereas microglia only 
produce cell-bound NG2 at low levels in response to TGF but do not secrete NG2. 
 
NG2 is not required in EAE. 
The TGF-induced increase in NG2 expression in OPCs and macrophages, which 
may underlie the accumulation of NG2 at sites of leukocyte infiltration, is likely to be 
an important response of the CNS to injury, however its function is currently unclear.  
Therefore, we subjected NG2-deficient (NG2ko) mice (de Castro et al. , 2005, Grako 
et al. , 1999, Kucharova and Stallcup, 2010 Mar 10) and littermate control (WT) mice 
to EAE and followed disease progression (Fig. 3A) and weight loss (Fig. 3B). The 
absence of NG2 has no significant effect on EAE onset, disease severity or the extent 
or rate of recovery.  
To investigate if the lack of NG2 influences demyelination, neuronal damage and/or 
astrocyte activation, histology on thoracic spinal cord cross-sections was performed 
(remission stage) (Fig. 3C). Quantitation of luxol fast blue (LFB) staining revealed 
that the extent of demyelination is similar in NG2ko and WT mice (Fig. 3D). Also the 
number of APP positive deposits, indicative of damaged neurons, and GFAP positive 
astrocytes are comparable in WT and NG2ko animals.  
The expression of NG2 by macrophages in vitro and the accumulation of NG2 at sites 
of leukocyte infiltration suggested that NG2 might modulate the inflammatory 
response in EAE. Therefore different leukocyte subsets were monitored during the 
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course of EAE in the CNS, spleen and inguinal lymph nodes by histology and flow 
cytometry but were not found to differ between NG2ko and WT mice (Fig. 3C-E; 
spleen and lymph node data not shown). Specifically, histology showed that at 
remission (d29) infiltrating T-cells (CD3), B-cells (B220), and macrophages (Mac-3) 
are present in comparable numbers in the CNS of WT and NG2ko mice (Fig. 3C and 
D). In agreement, flow cytometric analysis at remission did not reveal differences in 
any of the leukocyte populations tested, including T-cells, granulocytes, different 
dendritic cell types, microglia, and importantly, blood-derived macrophages (Fig. 3E, 
CNS). 
Since NG2 is prominently accumulated within and around areas of leukocyte 
infiltration, we assessed whether the size and location of the infiltrates within the 
thoracic and lumbar spinal cord (lumbar not shown) are altered in NG2ko mice during 
the peak phase by immunohistochemistry (Fig. 3F). Investigation of the distribution 
of macrophages/activated microglia (CD11b & F4/80) indicates that cell number, total 
area covered by the cells and penetration of the cells into the spinal cord in relation to 
the meninges are comparable in WT and NG2ko mice. Note though the quite 
prominent overlap in macrophage distribution (CD11b & F4/80) and NG2 
immunoreactivity in WT mice. 
Finally, because remyelination may be inhibited by NG2 accumulation (Larsen et al. , 
2003) or delayed by NG2-deficiency (Kucharova and Stallcup, 2010 Mar 10), we 
determined the extent and quality of remyelination by electron microscopy at d40 p.i. 
and in healthy control animals of each genotype (Fig. 4A - E). Quantitation of the 
percentage of myelinated axons, axon diameter, myelin thickness and G-ratio 
indicates that axon integrity and remyelination are comparable between healthy WT 
and healthy NG2ko mice and at d40 p.i. between both genotypes. As expected though, 
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myelination is reduced in d40 p.i. animals of both genotypes compared to myelination 
in healthy controls. The similar increase in the G-ratio at d40 p.i. strongly suggests 
that initial demyelinated was extensive in the experimental groups. The comparable 
G-ratios between WT and NG2ko animals at d40 p.i., however, show that 
remyelination occurs with similar efficiency in both genotypes. In summary, NG2 
deficiency has no influence on EAE disease outcome, the extent of CNS tissue 
damage, cellular inflammatory response, demyelination or remyelination. 
 
CNS resident cells are responsible for NG2 accumulation within and around 
infiltrates.  
Although our in vitro data indicates that both OPCs and macrophages up regulate and 
secrete NG2 in response to TGF, it still remains to be established if these cell types 
actually contribute to NG2 accumulation at sites of leukocyte infiltration in the CNS 
during EAE. Furthermore, it is possible that NG2 expression by OPCs or 
macrophages may have different or even opposite functions in CNS inflammation. To 
resolve these issues the following bone marrow chimeras were created: WT mice 
containing NG2ko bone marrow (KOWT) resulting in mice with NG2 deficiency 
only in the immune compartment, NG2ko mice containing WT bone marrow 
(WTKO) creating mice that express NG2 only in bone marrow-derived leukocytes, 
and wild type mice containing WT bone marrow (WTWT) as controls. We 
subjected these different groups to EAE and, in good agreement with the previous 
results (Fig. 3), weight-loss, onset, severity and progression of EAE were all 
comparable in the different chimeras (Fig. 5A and B) indicating that CNS- and 
leukocyte-derived NG2 do not have opposing or compensatory roles.  
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To determine the relative contribution of CNS-resident and CNS-infiltrating cells to 
the increase in NG2 in the spinal cord during EAE, the expression of soluble and 
detergent-extracted NG2 was examined by Western blot (remission) (Fig. 5C and D). 
Both 300-kDa cell-bound and 290-kDa shed NG2 are significantly elevated in 
WTWT and KOWT chimeras compared to NG2 levels in naïve WT mice. 
Notably, the amounts of soluble and cell-bound NG2 do not differ significantly 
between these two chimeras. In sharp contrast, in spinal cord lysates from WTKO 
chimeras cell-bound and soluble NG2 were never detected by Western blotting. 
Analysis of thoracic spinal cord for NG2 and CD11b immunoreactivity by confocal 
microscopy showed that the location and number of infiltrating CD11b+ leukocytes do 
not vary significantly between the different chimeras (Fig. 5D). However, the 
distribution of NG2 is strikingly different. WTWT chimeras show NG2 
accumulated within and around the area covered by the infiltrating cells and co-
localization of CD11b and NG2-immunoreactivity can on occasion be observed 
(inserts). Importantly, the distribution and accumulation of NG2 in the KOWT 
chimeras is comparable and also in these chimeras occasional CD11b and NG2 co-
localization can be seen, albeit significantly less frequently. In contrast, increased 
NG2 expression and accumulation at sites of leukocyte infiltration are clearly 
abolished in WTKO chimeras. Within the infiltrate occasionally NG2-expressing 
cells (insert), which are also dimly CD11b+, can be observed. NG2-expressing cells 
were never detected outside infiltrates in WTKO chimeras. Notably though, the 
majority of CD11b+ leukocytes do not express NG2. On average, 3 to 4 NG2+ cells 
are present within an infiltrate, which are all dimly CD11b+. 
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Taken together, these results indicate that, although some blood-borne NG2+ /CD11b+ 
macrophages are present in the CNS during EAE, CNS resident cells are responsible 
for the increase in NG2 and its accumulation at sites of leukocyte infiltration.  
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Discussion  
OPCs are the source of accumulated NG2 at sites of leukocyte infiltration in EAE. 
The prominent increase in NG2 mRNA and protein in the CNS during the course of 
EAE can in theory be derived from various cellular sources. In particular OPCs, CNS-
infiltrating macrophages and CNS-resident microglia are likely to express or up-
regulate NG2 during EAE. Indeed, our in vitro data shows that all three cell-types are 
able to express or up-regulate NG2 expression in response to TGF but not in 
response to various other cytokines that have been shown to play a role in EAE. In 
addition, of the various cytokine expression profiles we tested only expression of 
TGF correlated well with the expression of NG2 over the course of EAE, suggesting 
that TGF signaling may trigger increased NG2 expression in EAE.  
To determine which of the aforementioned cell types contribute to NG2 accumulation 
in the CNS we induced EAE in various NG2ko bone marrow chimeras. Our data 
shows that large amounts of NG2 are only accumulated in and around areas of 
leukocyte infiltration if the recipient mice have a wild-type background (KOWT 
and WTWT chimeras) showing that increases in NG2 are derived from a CNS-
resident cell type. Although it is possible that the lack of NG2 on peripheral cells, in 
particular leukocytes, may hamper CNS infiltration, which in turn could explain the 
lack of NG2 accumulation in the CNS, our immunohistochemical and flow cytometric 
data (latter not shown for chimeras) showing a comparable degree of cellular 
infiltration and lesion size argues against this possibility. 
Notably, in WTKO chimeras, in which NG2 is expressed by bone marrow-derived 
cells (leukocytes) and not by CNS resident cells, only a small amount of NG2 is 
present in the CNS at peak EAE. Notably, lesion size and leukocyte infiltration into 
the CNS are comparable to control EAE-diseased mice. This small amount of NG2 is 
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expressed solely by not yet fully characterized, but bone marrow-derived, CD11b+ 
amoeboid-shaped cells. The actual amount of NG2 expressed by these cells in the 
spinal cord of WTKO chimeras was too low to be detected by western blot. Thus, 
NG2 found in and around lesion sites in the CNS during the course of EAE is derived 
from CNS resident cells rather than from leukocytes infiltrating from the periphery 
into the CNS, practically ruling out blood-borne macrophages as a major source of 
NG2 in EAE. These data agree with observations by Rhodes et al. showing that NG2 
increases before ED1+ macrophages infiltrate into LPS injected rat brains (Rhodes et 
al. , 2006).  
Arguably, microglia as one of the potential brain resident sources of NG2 are unlikely 
to contribute to NG2 accumulation during EAE because of two observations. Firstly, 
even in the presence of TGF, the amount of cell-bound NG2 expressed by microglia 
in vitro is negligible, and shed NG2 is not produced at all by microglia, which is in 
good agreement with microarray data from our lab indicating that NG2 is not 
expressed by TGF-treated primary microglia (Paglinawan et al. , 2003). Secondly, in 
KOWT chimeric mice, in which NG2 is only expressed by CNS resident cells and 
not by leukocytes, only sporadic co-localization between NG2 and the 
microglial/macrophage marker CD11b is observed despite leukocyte infiltration into 
the CNS and lesion sizes being indistinguishable from control EAE-diseased mice. 
Although the latter observation suggest that some microglia may express NG2 during 
EAE, the amount produced by these cells cannot account for the large NG2 deposits 
observed in and around infiltrates. 
Taken together, our data rather suggests that OPCs responding to TGF are the source 
of accumulated NG2 in areas of CNS injury because Olig2+ OPCs are prominently 
present in and around infiltrates (Supplementary Fig. 3) and, in vitro, OPCs produce 
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significantly larger amounts of both cell-bound and soluble NG2 in response to TGF 
than macrophages and microglia. Our data is in accord with the observation that a 
single injection of TGF into the rat basal ganglia elicits OPC activation and 
increased NG2 immunoreactivity (Rhodes et al. , 2006). Functionally, TGF may 
induce a reactive phenotype in OPCs with a concomitant increase in NG2 expression, 
which may precede differentiation into oligodendrocytes and subsequent 
remyelination (McKinnon et al. , 1993).  
 
Notably, the localization of accumulated NG2 at sites of leukocyte infiltration appears 
rather diffuse and has a lack of distinct cellar structure indicating that NG2 is partly 
shed and incorporated into the extracellular matrix, which is confirmed by our 
Western blot data showing significant increases in both saline-soluble and detergent-
extracted NG2. Interestingly, the shedding of NG2 appears to be a common response 
in CNS injury because increases in both shed and cell-bound NG2 have also been 
described in knife lesions of rat cerebral cortex (Asher et al. , 2005). Although the 
functional significance of shed NG2 is currently unclear, the ability of the shed 
domain to bind various growth factors and extracellular matrix components suggests 
that it may function as a molecular “sink”, sequestering growth factors thereby 
limiting cell migration and/or proliferation. However, our data clearly shows that 
NG2 does not limit leukocyte proliferation and migration within the CNS or impairs 
clinical recovery in EAE. Notably, the latter observation, the presence of Olig2+ 
OPCs in and around areas of leukocyte infiltration (Supplementary Fig. 3), and the 
comparable extent of remyelination between NG2ko and WT mice at the late 
remission phase also imply that OPC migration, proliferation and differentiation are 
neither majorly hampered by NG2 accumulation nor by NG2 deficiency.  
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Unfortunately the diffuse appearance of the NG2 staining in infiltrates also makes it 
impossible to determine the number of NG2+ OPCs and NG2+/CD11b+ macrophages 
within these infiltrates by immunohistochemistry. Additional attempts to quantify 
these cell populations by flow cytometric analysis were also unsuccessful due to the 
lack of anti-NG2 antibodies that work in FACS.  
 
NG2+ macrophages in EAE. 
Many recent reports have suggested that macrophage- and/or microglia-like NG2+ 
cells accumulate in the CNS after a variety of insults (Bu et al. , 2001, Fiedorowicz et 
al. , 2008, Gao et al. , 2010, Hampton et al. , 2004, Jones et al. , 2002, Matsumoto et 
al. , 2008, Rezajooi et al. , 2004, Smirkin et al. , 2009 Mar, Wu et al. , 2010, 
Yokoyama et al. , 2006, Zhu et al. , 2010 Mar 31), despite this large body of data, 
claims made in earlier studies indicating that NG2+ cells are quite distinct from 
macrophages and microglia still cast some doubts on the existence of NG2+ 
macrophages (Dawson et al. , 2000, Di Bello et al. , 1999, Levine, 1994, Nishiyama 
et al. , 1997). Some of these original studies have argued that the occasional NG2+ 
microglia/macrophage engulfed or phagocytized rather than synthesized NG2 
(Levine, 1994, Nishiyama et al. , 1997). Our data shows that the existence of a 
macrophage-like NG2+ cell in the CNS after insult can no longer be logically 
disputed. NG2+/CD11b+ cells are clearly present in leukocyte infiltrates in the spinal 
cord of EAE diseased chimeras in which the CNS is NG2 deficient (WTKO 
chimeras). Furthermore, our in vitro data demonstrates that NG2 expression can be 
induced in bone marrow-derived macrophages (CD11b+ and F4/80+ expression of 
these cells shown in (Moransard et al. , 2010 Apr)). Concurrent with our data is the 
observation of NG2+/F4/80+ macrophages outside the CNS (Tigges et al. , 2008). The 
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quantitative appreciation of the NG2 expression by macrophages in EAE lesions is 
difficult due to the fact that the usually strongly CD11b+ cuffs of the macrophages are 
“flooded” by soluble NG2. Interestingly, our observations in the NG2 chimeras show 
that NG2+/CD11b+ cells constitute a remarkably small part of all the CD11b+ cells 
present in infiltrates in the CNS indicating that these cells form a distinct 
subpopulation. This small number of NG2+/CD11b+ cells probably explains why 
these cells have evaded conclusive identification for so long. 
Notably, the studies mentioned above have used slightly different panels of antibodies 
and as a consequence it is not quite clear if we have identified the same cell 
population or if there are different subpopulations of NG2+ macrophage-like cells. 
The NG2+ cells we observe in the WTKO chimeras are dimly CD11b+ and a 
proportion of these cells also express the DC marker CD11c (data not shown), which 
would correspond well with the NG2+/OX42+ cells identified by a number of groups 
(Bu et al. , 2001, Fiedorowicz et al. , 2008, Gao et al. , 2010, Hampton et al. , 2004, 
Wu et al. , 2010, Zhu et al. , 2010 Mar 31), which may be myeloid or inflammatory 
dendritic cells (Hesske et al. , 2010 Jun, Mildner et al. , 2009). 
 
NG2 plays no role in EAE. 
Despite the fact that a number of reports have identified immune cells that express 
NG2 (Bu et al. , 2001, Fiedorowicz et al. , 2008, Gao et al. , 2010, Hampton et al. , 
2004, Jones et al. , 2002, Matsumoto et al. , 2008, Rezajooi et al. , 2004, Smirkin et 
al. , 2009 Mar, Wu et al. , 2010, Yokoyama et al. , 2006, Zhu et al. , 2010 Mar 31) 
and increases in NG2 appear to be a pronounced injury response both in the CNS and 
PNS (Asher et al. , 2005, Di Bello et al. , 1999, Hossain-Ibrahim et al. , 2007 Sep 27, 
Jones et al. , 2002, Levine, 1994, Moon and Fawcett, 2001, Morgenstern et al. , 2002, 
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Nishiyama et al. , 1997, Reynolds et al. , 2002, Rezajooi et al. , 2004, Tan et al. , 
2005, Tang et al. , 2003), in depth studies investigating the role of NG2 in the 
immune response have been lacking. Only two recent studies have tried to address the 
role of NG2+ macrophage/microglia-like cells in CNS inflammation directly. Data by 
Goa et al. indicate that NG2 mediates the induction of iNOS and inflammatory 
cytokine but not chemokine expression in LPS-activated microglia (Gao et al. , 2010). 
A report by Smirkin et al. identifies several neuro-protective factors expressed by 
Iba1+/NG2+ macrophage-like cells and suggests that these cells may ameliorate 
ischemic brain damage (Smirkin et al. , 2009 Mar). However, our data demonstrates 
that NG2 deficiency has no significant effect on EAE progression, leukocytes 
extravasation or migration within the CNS, demyelination or the extent of neuronal 
damage, indicating that NG2 does not play an important role in macrophage/microglia 
function in autoimmunity. 
In addition, NG2 accumulation has no effect on remyelination. Although we did not 
address axon outgrowth directly, the comparably clinical recovery and extent of 
neuronal damage and de- and remyelination at remission in NG2ko mice and WT 
littermates indicate that NG2 is not a major inhibitory or stimulatory factor in axon 
outgrowth, which is in good agreement with the lack of improvement in axon 
outgrowth observed in the NG2ko mouse after spinal cord injury (de Castro et al. , 
2005, Hossain-Ibrahim et al. , 2007 Sep 27). 
In summary, the TGF-induced expression of NG2 in macrophages in vitro and 
expression of NG2 by a small population of blood-borne macrophages in the CNS of 
EAE diseased mice are indicative of a novel, potentially anti-inflammatory, 
macrophage subpopulation. However, neither CNS-derived nor peripheral 
macrophage expressed NG2 plays a role in the course of CNS autoimmunity. Finally, 
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although we have established here that shed and accumulated NG2 is derived from 
CNS resident OPCs, the biological role of this rather prominent response of the CNS 
to injury remains an open question. 
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Materials and Methods 
Mice 
Seven to eight week old C57Bl/6 female mice were purchased from Harlan (the 
Netherlands). NG2 knockout mice were a kind gift from Prof. William B. Stallcup, 
Burnham Institute for Medical Research, La Jolla, CA, USA and backcrossed to 
C57Bl/6 background for 9 generations.  
To generate bone marrow-chimeras, mice were lethally irradiated with a split-dose of 
1000 rad. Donor animals were euthanized with CO2 and bones (fore- and hind legs, 
hips) were flushed with sterile PBS to obtain bone marrow stem cells. In total, 5×106 
total bone marrow cells were injected i.v. per mouse. To prevent bacterial infection 
1% Neomycin (Sigma) was added for 2 weeks to the drinking water. After 6 weeks, 
prior to MOG immunization, reconstitution was verified by flow cytometry with anti-
CD45.1 and anti-CD45.2 (BD PharMingen) on circulating leukocytes isolated from 
blood samples. Average reconstitution exceeded 97%.  
All animal experiments were approved by the Swiss Veterinary Office (115/05; 
Zurich, Switzerland) and performed according to federal and institutional guidelines. 
Reagents  
Cytokines, growth factors and chemicals were obtained from the following sources. 
Roche Diagnostics: mTNFα and mIFNγ. PeproTech: rmIL-1b, hIL-2, mIL-6, rmIL-
13, rhTGFβ 2, and M-CSF. BD PharMingen: rmIL-10. Antibodies to NG2 were either 
a kind gift from Prof. William B. Stallcup or obtained from Chemicon. Anti--
tubulin-HRP and anti--actin-HRP were purchased from Abcam and Sigma, 
respectively.  Antibodies to CD3 (biotin), CD4 (PE), CD8 (FITC), CD11b (biotin), 
B220 (biotin) and Gr1 (FITC), were obtained from BD PharMingen and F4/80 (FITC) 
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from Serotec. CD11b (unlabelled), CD16/32 (Fc block) and CD45 (APC) were 
purchased from Biolegend and CD11c (clone N418, PE) from Caltag. The secondary 
antibody anti-rabbit HRP was obtained from Pierce. Anti-rat Alexa 488 and anti-
rabbit Alexa 594 were purchased from Molecular Probes/Invitrogen and Streptavidin-
APC-Cy7 Biolegend. 
EAE induction  
Mice were injected with 100 μg MOG35-55 (Anawa, Switzerland) in 200 μl 
PBS/CFA (DIFCO, USA) (1:1) subcutaneously on the right flank and with 300 ng 
Pertussis toxin (List Biological Laboratories, USA) intraperitoneal (i.p.) on day 0, 
followed by a boost of 300 ng Pertussis Toxin at day 2 and 100 μg MOG35 in CFA 
into the left flank on day 7. The scoring of clinical symptoms was performed as 
described previously (Moransard et al. , 2010 Apr).  
Primary cells and cell lines 
Primary oligodendrocyte progenitor cells (OPCs) were isolated as described 
previously (Moransard et al. , 2010 Apr). Briefly, neonatal forebrain cells were 
harvested from 1-2 day old neonates C57/BL6 mice by dissociation of cortices in 
Papain (Sigma) and grown in DMEM (Gibco) supplemented with 10% horse serum 
(HS) (Gibco) on poly-D-lysine (Sigma)-coated cell culture flasks. After 10 days the 
loosely attached OPCs were separated from the glial feeder layer by 16 h of 
mechanical shaking at 210 rpm, 37°C. The collected OPCs were further cultured 
either in SATO medium as described previously (Moransard et al. , 2010 Apr) or in 
DMEM/F12 (Gibco), 10 mom N-Acetyl-L-alary-L-glutamine (L-GLU) (Biochrom 
AG, Germany), 1% Pen-Strep (Gibco), 2% B-27 supplement (Gibco) on poly-D-
lysine coated cell culture flasks. 
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Bone marrow-derived macrophages (BMM) were prepared from bone marrow cells 
isolated from the femur and tibia. Bones were flushed with HBSS and the cell 
suspension was forced through a 70-μm mesh. Collected cells were re-suspended in 
complete macrophage medium containing DMEM, 30% L929 cell-conditioned 
medium (source of M-CSF), 20% HS, 10 mom HEPES (Gibco) and 10 mom L-GLU 
and cultured at 37°C, 5% CO2. After 7 days virtually 100% of the cells expressed the 
macrophage markers CD11b and F4/80. The cells were harvested by scraping on ice 
and frozen in 90% FCS and 10% DMSO at a density of 5×106-10×106 cells/ml. 
Thawed cells were cultured in either DMEM containing 10% fetal calf serum (FCS) 
(PAA Laboratories GmbH, Austria), 2 mom L-GLU and 20 mg/ml gentamicin 
(Sigma) or the same medium without serum.  
BV2 cells (lab stock) were cultured in DMEM containing 10% FCS, 2 mom L-GLU 
and 20 mg/ml gentamicin. 
OLIneu cells (kindly provided by Dr. J. Trotter) were cultured as described for 
primary OPCs.  
To determine NG2 expression, all cell types were seeded on 3 cm culture dishes at 
1.0-2.0×106 cells/dish and treated with cytokines for 48 h prior to real time PCR or 
Western blot analysis. For immunocytochemistry, cells were grown at similar 
densities on glass cover slips. 
Isolation of CNS-mononuclear cells  
CNS-mononuclear cells were isolated as described previously (Moransard et al. , 
2010 Apr). Briefly, brains and spinal cords of animals perfused with Hanks' balanced 
salt solution (HBSS) were minced with a scalpel blade and digested for 30’ at 37°C in 
HBSS containing 50 mg/ml DNase I and 100 mg/ml Collagenase/Dispase (Roche). 
The digestion was quenched on ice and passed through a 100 μm Nylon mesh (BD 
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Biosciences) and centrifuged after which the pellet re-suspended in 30% Percoll 
(Sigma). The gradient was centrifuged at 29000 x g for 30 min at 4°C (Kontron 
Instruments, Germany). The top layer containing myelin was removed by aspiration, 
and the interphone containing mononuclear cells was collected, diluted threefold with 
HBSS and collected by centrifugation at 300 x g.  
Flow cytometric analysis 
Cells were re-suspended in FACS buffer containing 2% FCS, 5 mom EDTA, 0.01% 
NaN3 in phosphate buffered saline (PBS). Prior to staining with the appropriate 
antibodies, Fc receptors were blocked by incubation with anti mouse CD16/32 (Fc-
block, BD PharMingen). 7-Amino-actinomycin D (7-AAD) was used to exclude non-
viable cells. All flow cytometric data was obtained with a CyFlow flowcytometer 
(Partec, Germany). Data analysis was performed with FlowJo. 
Infiltrating mononuclear cells were distinguished from CNS-resident microglia 
(CD45int/CD11b+/F4/80+) on the basis of their high CD45 expression. Within this 
population the following cell types were distinguished using gating as indicated 
between brackets: CD4 T cells (CD3+/CD4+), CD8 T cells (CD3+/CD8+), 
Granulocytes (CD11b+/Gr1+), lyDCs (lymphoid dendritic cells; CD11c+/CD11b-
/F4/80-), myDCs (myeloid DCs; CD11c+/CD11b+/F4/80-), inflDCs (inflammatory 
DCs; CD11c+/CD11b+/F4/80+), pDCs (plasmacytoid DCs; CD11c+/B220+/Gr1+), B 
cells (CD11c-/B220+/Gr1-), Macrophages (CD11c-/CD11b+/F4/80+). 
Western blotting 
To determine the amount of cell-bound NG2, cultured cells were scraped on ice in 
lysis buffer containing 1% Nonidet P 40 (NP-40, Igepal CA 630, Fluka), 50 mom 
Tris, 150 mom NaCl, 5 mom EDTA and a cocktail of proteinase inhibitors (Complete 
Mini, Roche), after which the lysates were cleared from insoluble material by 
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centrifugation. To determine the amount of secreted NG2, cell-conditioned media 
were collected and concentrated 10 fold using Amicon Ultra centrifugal filter devices 
with a cut-off of 100 kDa (Amicon). Both lysates and cell conditioned-media were 
incubated for 3 hrs at 37°C with Chondroitinase ABC (Sigma) in order to remove the 
chondroitin side chain of NG2 prior to incubation with an appropriate volume of 
Laemmli buffer at 80°C.   
The protocol to isolate soluble and detergent-extractable NG2 fractions from CNS 
tissue is based upon the methods published by Asher et al. (Asher et al. , 2005). In 
brief, spinal cords isolated from EAE diseased mice were homogenized on ice with a 
douncer in the same buffer as used for cultured cells but omitting NP-40. The 
resulting lysate was cleared of insoluble material by low-speed centrifugation (3000g, 
10 min). The supernatant contains soluble NG2, whereas detergent-extractable NG2 
was recovered by re-suspending the pellet in lysis buffer containing 1% NP-40. 
Finally both lysates were cleared from remaining insoluble material by centrifugation 
(15000g, 10 min) followed by determination of the protein concentration using a BCA 
protein assay kit (Pierce) and incubation with an appropriate volume of Laemmli 
buffer at 80°C. 
For Western blotting for NG2 equal amounts of protein were loaded on NuPAGE 3-
8% Tris-Acetate gels (Invitrogen). Probing for -tubulin and/or -actin was 
performed to control for loading. Images of Western blots were obtained and 
quantified using the GE Health care ImageQuant 350 system and accompanying 
software. 
Immunohistochemistry/Immunocytochemistry 
Mice were CO2 anesthetized and perfused with 25 ml Ringer solution (Braun Medical 
AG, Switzerland). Immunohistochemistry was performed on 10-15 μm frozen, 4% 
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PFA- or methanol-fixed longitudinal or cross sections of thoracic and lumbar spinal 
cord. Sections were thawed, fixed and blocked (5% FCS, 0.01% triton, PBS) prior to 
incubation with primary antibody 1/200 in block buffer for 24 h. After washes with 
PBS, sections were incubated with the appropriate secondary antibody in block buffer 
for 2 h. After counterstaining with DAPI (Molecular Probes) sections were mounted 
in Mowiol embedding medium (Mowiol 4-88, Calbiochem) containing 0.1% 1,4-
Diazabicyclo-82.2.29-octan (DABCO, Fluka). Immunocytochemistry on cultured 
cells was performed using the same protocol directly after a short wash and fixation 
of the cells with 4% PFA for 10 minutes. Images were obtained on either a Zeiss 
Axiovert 40 or a Leica SP 5 confocal microscope. 
Histology 
Mice were sacrificed with CO2. Histology was performed as described recently (Prinz 
et al. , 2006). Spinal cords were removed and fixed in 4% buffered formalin and 
embedded in paraffin before staining with hematoxylin eosin (H&E) or luxol fast blue 
(LFB) to assess the degree of demyelination, MAC-3 (BD PharMingen) for 
macrophages and microglia, CD3 for T cells (Serotec), B220 (BD PharMingen) for B 
cells, APP for amyloid precursor protein (Chemicon), and GFAP for astrocytes 
(Dako). 
Electron microscopy and evaluation of remyelination 
Electron microscopy and evaluation of remyelination was performed as recently 
described (Raasch et al. , 2011): Epon-embedded, glutaraldehyde-fixed spinal cord 
slices from lumbar spinal cords (L1-L4) from 5 WT and 5 NG2 animals at d40 p.i. 
and 4 WT and 3 NG2 age and sex matched healthy control animals were prepared, cut 
and stained with toluidine blue. This staining allowed clear distinction between 
normal and inflamed white matter already by light microscopy. The tissue was then 
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trimmed and re-orientated so that ultrathin cross sections of the spinal cord could be 
cut and treated with urinal acetate and lead citrate. 30 Electron micrographs from 
within spinal cord sections were obtained at 13500-fold magnification from each 
animal. Of these 10 images for each animal were randomly selected and axon 
diameter and myelin thickness were measured using the analySIS Dock System (Soft 
Imaging System GmbH, Germany). Within each image all axons with diameters of 
larger than 250 nm were evaluated, axons with smaller diameters were omitted, since 
these are usually un-myelinated axons. This meant that at least 130 axons per animal 
were evaluated. G ratios were defined as diameter of the axon divided by fiber 
diameter (axon plus myelin). We calculated a G ratio for each fiber and subsequently 
averaged all G ratios from one spinal cord. In addition, the number of myelinated 
fibers in relation to all fibers was expressed as percentage of myelinated axons to all 
visible axons. Electron micrographs were obtained using a Philips CM 100 electron 
microscope. 
 
RNA isolation and real time PCR 
Whole-cell RNA from cultured cells was extracted using the NucleoSpin-RNA II kit 
(Macherey-Nagel, Switzerland). RNA from mouse tissues was extracted by 
homogenization in TRIzol (Invitrogen) according to the manufacturer’s instructions. 
RNA was reverse-transcribed using random hexamers and AMV reverse transcriptase 
(Promega). The cDNA equivalent to 50 ng of total RNA was PCR-amplified in an 
ABI PRISM 7700 detection system (PE-Applied Biosystems) using TaqMan 
Universal PCR Master Mix (Applied Biosystems) and quantified using the 2-CT 
method using 18s rRNA as a housekeeping gene. Relative RNA levels are expressed 
as x-fold variations compared to control. Primers and probes for Taqman analysis for 
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IL-2, IL-6, IL-10, TNFα, IFN, TGF and NG2 were purchased from Applied 
Biosystems.  
Proliferation assay 
OLIneu were seeded in a 96 well plate and treated with cytokines for 16 h before the 
addition of 5 µCi/ml 3H-thymidine (GE Healthcare). After incubate for 16 h at 37°C 
the cells were harvested directly onto a glass fiber filter membrane using a 96-well 
plate harvester. The filters were dried at 60°C, sealed in a plastic bag containing 
scintillation fluid (PerkinElmer) and measured in a beta-counter (PerkinElmer). 
Statistical analysis 
For data obtained in vivo we performed unpaired, two-tailed Student’s t-tests 
assuming equal variances. For data obtained in vitro we performed paired, two-tailed 
Student’s t-tests assuming equal variances. Numbers following the ± sign represent 
standard error (s.e.m). 
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Figure legends 
 
Figure 1. NG2 is up regulated and accumulated in and around areas of leukocyte 
infiltration at peak and remitting stages of EAE.  
(A) Quantitative RT-PCR analysis of NG2 and cytokine mRNA expression in spinal 
cord at different EAE stages. NG2 mRNA expression is significantly increased at 
peak and remission (rem.). The expression of NG2 mRNA correlates well with TGF 
mRNA expression, but not with the expression of IL-2, IL-6, IL-10, TNF or IFN. 
(B, C) Western blot and corresponding densitometric quantitation of soluble and 
detergent-extracted NG2 in spinal cord lysates from EAE diseased mice. Both soluble 
and detergent-extracted NG2 protein amounts are significantly elevated in spinal cord 
at peak and remission (rem.). (D) Immunohistochemistry for NG2 in longitudinal 
sections of spinal cord. In the spinal cord of naïve animals NG2 expression is 
confined to blood vessels and oligodendrocyte progenitor cells (OPCs). Insert shows 
an electronically 3x magnified image of a stellate OPC in the boxed area. At peak and 
remission, NG2 immunoreactivity is increased in and around areas of infiltrating 
leukocytes, identified by DAPI staining as clustered nuclei. NG2 immunoreactivity is 
diffuse and does not resemble the classic OPC morphology. Inserts show 
electronically 3x-magnified images of the boxed areas. In normal appearing spinal 
cord at remission (rem. n.a. Sp.C.), NG2 immunoreactivity is not increased and is 
localized to OPCs and blood vessels. Bars represent mean ± s.e.m., n=4 , *P<0.05, 
**P<0.01 versus naïve WT control. 
 
Figure 2. TGF induces expression and secretion of NG2 by macrophages and 
OPCs in vitro.  
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(A) Analysis of NG2 mRNA expression in (primary bone marrow-derived) 
macrophages (Mac.) and OLIneu treated with different cytokines (24 hrs) by 
quantitative RT-PCR. NG2 expression is significantly increased by treatment with 
TGF in OLIneu and macrophages. IL-6 also increases NG2 expression in OLIneu. 
(B) Representative Western blot for NG2 of primary OPC lysates and culture medium 
after 48 hrs of TGF treatment. TGF up regulates both cell bound and secreted NG2. 
(C, D) Western blot for NG2 of macrophage lysates and culture medium after 
cytokine treatment (24 hrs) and corresponding densitometric quantitation. Untreated 
macrophages express and secrete a small amount of NG2. TGF elicited a significant 
increase in cell-bound and secreted NG2. (E) Treatment of the microglia cell line 
BV2 with cytokines followed by Western blot analysis of cell lysates and culture 
media. Microglia express cell-bound NG2 only after TGF treatment. Secreted NG2 
could not be detected. (F) Comparative Western blot of NG2 expression in 
macrophages, microglia (Micr.) and primary OPCs. Macrophages express a modest 
amount of NG2 although at lower levels than expressed by OPCs. NG2 expressed by 
microglia is barely detectable. (G) Immunocytochemistry for NG2 in OLIneu, 
macrophages and microglia after cytokine treatment. TGF treatment induces an 
increase in NG2 immunoreactivity in OLIneu. TGF elicits NG2 expression in most, 
but not all, macrophages (co-stained with CD11b). NG2 immunoreactivity is never 
detected in microglia. Bars represent mean ± s.e.m., n=4, *P<0.05, **P<0.01 versus 
control.  
 
Figure 3. NG2 deficiency does not alter EAE disease progression or 
inflammatory profile.  
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(A) EAE progression monitored in mice immunized with MOG using a method that 
scores the degree of paralysis on a 1 to 5 scale. Shown are the combined results of 2 
independent experiments with 24 NG2 deficient (NG2ko) and 36 WT animals in total. 
(B) Progression of weight loss of the same mice. The fluctuations in weight correlate 
well with the degree of disability. NG2-deficiency has no effect on EAE progression. 
(C, D) Histology and corresponding quantitation of thoracic spinal cord cross sections 
from EAE diseased NG2ko and WT mice at the remission stage for myelin loss (LFB; 
luxol fast blue), neuronal damage (APP; amyloid precursor protein), astrocyte 
proliferation (GFAP; glial fibrillary acidic protein), and infiltration of macrophages 
(MAC-3) and T-cells (CD3). In addition the number of infiltrating B cells was 
assessed (B220). No significant differences in the number of infiltrating cells or 
degree of demyelination or neuronal damage were detected (n=5). (E) Flow 
cytometric analysis of CNS-infiltrating leukocytes. No significant differences were 
found in any of the leukocyte populations tested. For gating strategy and definition of 
leukocyte populations see Methods. Bars represent mean ± s.e.m., n=4. (F) 
Immunohistochemistry for macrophages/microglia (CD11b and F4/80) on thoracic 
spinal cord cross-sections (peak). In WT animals, NG2 accumulation appears 
associated with infiltrates of CD11b and F4/80 positive macrophages/microglia. The 
number of infiltrating cells and area occupied does not noticeably differ between WT 
and NG2ko animals.  
 
Figure 4: Normal myelination and remyelination in the absence of NG2. 
(A) Spinal cord sections from WT and NG2 animals d40 p.i. and from sex- and age-
matched healthy controls. First row: Toluidine Blue stained sections (scale bars = 500 
µm), box depicts areas evaluated for myelination. Second row: magnified sections 
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from first row (scale bars = 100 µm). Third row: Electron micrographs of evaluated 
regions (scale bars = 1 µm). (B-E) Percentage of myelinated axons compared to all 
visible axons (B), average axon diameter (C), average myelin thickness (D) and 
average G-Ratio (E) show no significant differences between WT and NG2 animals 
in either the d40 p.i. or the control groups. (P-values >0.1). Animals at d40 p.i. show 
significantly reduced myelination compared to healthy control animals (*=P<0.05; 
**=P<0.01). In all the graphs, each data point represents an individual animal. Mean 
values are also depicted. 
 
Figure 5. CNS resident cells are responsible for increased NG2 expression and 
accumulation in and around areas of leukocyte infiltration. (A, B) EAE 
progression and weight loss of the different chimeras. WTWT n=10, KOWT 
n=8, WTKO n=8. The fluctuations in weight correlate well with the degree of 
disability. EAE progression is comparable in all groups. (C, D) Western blot analysis 
and corresponding densitometric quantitation of NG2 in spinal cord of EAE diseased 
chimeras at remission. Soluble and detergent-extracted NG2 amounts are elevated in 
WTWT and KOWT chimeras compared to naïve WT controls. NG2 is not 
detected in WTKO spinal cord lysates. Increased cell-bound and secreted NG2 
protein amounts are comparable between WTWT and KWT chimeras. (E) 
Immunohistochemistry for CD11b and NG2 on thoracic spinal cord cross sections 
from EAE diseased chimeric mice at remission analyzed by confocal microscopy. 
WTWT chimeras show extensive NG2 accumulation in and around areas of 
leukocyte infiltration, which partly overlaps with CD11b immunoreactivity. 
KOWT mice show a similar degree of infiltration of CD11b+ cells and a 
comparable degree of NG2 accumulation. The overlap between CD11b and NG2 
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staining appears less frequent. WTKO animals show a comparable infiltration of 
CD11b+ cells. However, NG2 staining is almost completely absent. Only occasionally 
NG2+ cells can be detected in the infiltrate (inserts). These cells also express low 
levels of CD11b (overlay and insert). Arrows indicate CD11b and NG2 co-
localization. Inserts show electronically 2.35x-magnified images of the boxed areas. 
Bars represent mean ± s.e.m., n=4, *P<0.05, ***P<0.001 versus control.  
	
Supplementary Figure 1. TGF treatment does not alter OPC proliferation in 
vitro. 
Determination of proliferation of OLIneu treated with TGF, TNF, or IFN by 3H-
thymidine incorporation. 16h treatment of OLIneu with these cytokines did not alter 
proliferation.  
 
Supplementary Figure 2. TGF treatment increases cell-bound and secreted 
NG2 in OLIneu in a time dependent fashion. 
(A) TGF time-course treatment of OLIneu followed by Western blot analysis for 
NG2 of cell lysates and culture medium. (B) Corresponding densitometric 
quantitation. Cell-bound and secreted NG2 protein levels are significantly elevated 
after 24 hrs of TGF treatment. Bars represent mean ± s.e.m., n=4, *P<0.05 versus 
untreated control. 
	
Supplementary Figure 3. Olig2+ OPCs are detected within and around sites of 
leukocyte infiltration. 
Immunohistochemistry for Olig2 in transfer sections of thoracic spinal cord. In the 
spinal cord of peak EAE mice Olig2+ OPCs are found within (arrow) and in close 
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proximity (arrow heads) to sites of leukocyte infiltration (identified by a high 
concentration of DAPI stained nuclei).  
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